Sevil Özcan

483 total citations
19 papers, 402 citations indexed

About

Sevil Özcan is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Sevil Özcan has authored 19 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Sevil Özcan's work include Synthesis and Biological Activity (4 papers), Marine Sponges and Natural Products (3 papers) and Ubiquitin and proteasome pathways (3 papers). Sevil Özcan is often cited by papers focused on Synthesis and Biological Activity (4 papers), Marine Sponges and Natural Products (3 papers) and Ubiquitin and proteasome pathways (3 papers). Sevil Özcan collaborates with scholars based in United States and Türkiye. Sevil Özcan's co-authors include Metin Balcı, Ertan Şahi̇n, Harshani R. Lawrence, Saı̈d M. Sebti, Nicholas J. Lawrence, Yunting Luo, J. Zhu, Mathew P. Martin, E. Schönbrunn and Roberta Pireddu and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Sevil Özcan

19 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevil Özcan United States 12 188 174 75 59 56 19 402
Mark Charles United Kingdom 8 247 1.3× 205 1.2× 43 0.6× 48 0.8× 75 1.3× 9 498
Robyn D. Richardson United States 9 104 0.6× 228 1.3× 84 1.1× 56 0.9× 93 1.7× 9 426
Si-Tu Xue China 13 190 1.0× 199 1.1× 78 1.0× 26 0.4× 43 0.8× 30 432
Alexander P. Ducruet United States 9 146 0.8× 453 2.6× 96 1.3× 53 0.9× 29 0.5× 10 545
M. Manuela A. Pereira Portugal 10 235 1.3× 149 0.9× 123 1.6× 32 0.5× 93 1.7× 19 435
Wanren Li Austria 6 153 0.8× 156 0.9× 59 0.8× 20 0.3× 46 0.8× 7 385
Stuart C. Wilson United Kingdom 10 208 1.1× 305 1.8× 147 2.0× 94 1.6× 35 0.6× 14 555
Patricia Imbach Switzerland 11 170 0.9× 440 2.5× 158 2.1× 46 0.8× 27 0.5× 11 587
José D. Solano Mexico 13 159 0.8× 233 1.3× 59 0.8× 26 0.4× 47 0.8× 22 450
Helena Posteri Italy 10 160 0.9× 205 1.2× 107 1.4× 64 1.1× 15 0.3× 12 342

Countries citing papers authored by Sevil Özcan

Since Specialization
Citations

This map shows the geographic impact of Sevil Özcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevil Özcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevil Özcan more than expected).

Fields of papers citing papers by Sevil Özcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevil Özcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevil Özcan. The network helps show where Sevil Özcan may publish in the future.

Co-authorship network of co-authors of Sevil Özcan

This figure shows the co-authorship network connecting the top 25 collaborators of Sevil Özcan. A scholar is included among the top collaborators of Sevil Özcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevil Özcan. Sevil Özcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lawrence, Harshani R., Kiran Mahajan, Yunting Luo, et al.. (2015). Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach. Journal of Medicinal Chemistry. 58(6). 2746–2763. 37 indexed citations
2.
Kazi, Aslamuzzaman, et al.. (2014). Discovery of PI-1840, a Novel Noncovalent and Rapidly Reversible Proteasome Inhibitor with Anti-tumor Activity. Journal of Biological Chemistry. 289(17). 11906–11915. 21 indexed citations
3.
Özcan, Sevil, et al.. (2014). Evaluation of Oxidative Stress Biomarkers in Patients with Fixed Orthodontic Appliances. Disease Markers. 2014. 1–7. 39 indexed citations
4.
Sebti, Saı̈d M., et al.. (2014). Abstract 1810: PI-1840, a novel non-covalent and rapidly reversible proteasome inhibitor with anti-tumor activity. Cancer Research. 74(19_Supplement). 1810–1810. 1 indexed citations
5.
Lawrence, Harshani R., Yunting Luo, Dongke Zhang, et al.. (2014). Abstract 2511: New inhibitors the tyrosine kinase ACK1/TNK2 active in prostate, breast and pancreatic cancer. Cancer Research. 74(19_Supplement). 2511–2511. 1 indexed citations
6.
Özcan, Sevil. (2013). Synthesis of fused-tetrazolone derivatives. TURKISH JOURNAL OF CHEMISTRY. 2 indexed citations
7.
Özcan, Sevil, Frank Marsilio, Bin Fang, et al.. (2013). Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors. Journal of Medicinal Chemistry. 56(10). 3783–3805. 31 indexed citations
8.
Martin, Mathew P., J. Zhu, Harshani R. Lawrence, et al.. (2012). A Novel Mechanism by Which Small Molecule Inhibitors Induce the DFG Flip in Aurora A. ACS Chemical Biology. 7(4). 698–706. 54 indexed citations
9.
Lawrence, Harshani R., Mathew P. Martin, Yunting Luo, et al.. (2012). Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors. Journal of Medicinal Chemistry. 55(17). 7392–7416. 58 indexed citations
10.
Balcı, Metin, et al.. (2011). Synthesis of Indolin-2-one, Isoindolin-1-one, and Indole Derivatives from Homophthalic Acid. Synthesis. 2011(22). 3697–3705. 2 indexed citations
11.
Özcan, Sevil, Cagatay Dengiz, Murat K. Deliömeroglu, Ertan Şahi̇n, & Metin Balcı. (2011). A novel one-pot, three-component reaction for the synthesis of isocoumarin-condensed pyrazoles. Tetrahedron Letters. 52(13). 1495–1497. 18 indexed citations
12.
Özcan, Sevil, et al.. (2011). New synthetic methodology for construction of the 3,4-dihydroisoquinolinone skeleton: A key structure for isoquinoline alkaloids. Phytochemistry Letters. 4(4). 407–410. 17 indexed citations
13.
Katritzky, Alan R., et al.. (2010). Labeling of nucleosides with fluorescent 6-chloro-2,3-napthalimide. Bioorganic & Medicinal Chemistry Letters. 20(17). 5326–5328. 2 indexed citations
14.
Katritzky, Alan R., et al.. (2010). Synthesis and fluorescence of the new environment-sensitive fluorophore 6-chloro-2,3-naphthalimide derivative. Organic & Biomolecular Chemistry. 8(6). 1296–1296. 16 indexed citations
15.
Balcı, Metin, Cagatay Dengiz, Sevil Özcan, & Ertan Şahi̇n. (2010). New Synthetic Methodology for Construction of the 1,3,4,5-Tetrahydro-2H-1,3-benzodiazepin-2-one Skeleton. Synthesis. 2010(8). 1365–1370. 8 indexed citations
16.
Balcı, Metin, Murat K. Deliömeroglu, & Sevil Özcan. (2010). A short and efficient construction of the dibenzo[c,h]chromen-6-one skeleton. ARKIVOC. 2010(2). 148–160. 3 indexed citations
17.
Özcan, Sevil, et al.. (2009). Regioselective synthesis of the 3,4-dihydrofuro[3,2-d]pyrimidin-2(1H)-one skeleton: a new class of compound. Tetrahedron. 65(31). 5973–5976. 19 indexed citations
18.
Özcan, Sevil & Metin Balcı. (2008). The chemistry of homophthalic acid: a new synthetic strategy for construction of substituted isocoumarin and indole skeletons. Tetrahedron. 64(23). 5531–5540. 42 indexed citations
19.
Özcan, Sevil, Ertan Şahi̇n, & Metin Balcı. (2007). The synthesis of unusual isocoumarin derivatives: the chemistry of homophthalic acid. Tetrahedron Letters. 48(12). 2151–2154. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026